Close

Cerus (CERS) Inks Agreement with BARDA for RBC Component Pathogen Reduction Program

June 19, 2016 6:02 PM EDT Send to a Friend
Cerus Corporation (Nasdaq: CERS) announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login